Bruker Co. (NASDAQ:BRKR) Shares Sold by California Public Employees Retirement System

California Public Employees Retirement System lowered its stake in shares of Bruker Co. (NASDAQ:BRKR - Free Report) by 9.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 153,581 shares of the medical research company's stock after selling 16,593 shares during the period. California Public Employees Retirement System owned approximately 0.10% of Bruker worth $9,003,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of BRKR. Retirement Systems of Alabama grew its stake in shares of Bruker by 11.7% in the third quarter. Retirement Systems of Alabama now owns 134,254 shares of the medical research company's stock worth $9,272,000 after acquiring an additional 14,069 shares in the last quarter. Merit Financial Group LLC purchased a new position in Bruker during the 4th quarter worth approximately $300,000. Bank of New York Mellon Corp grew its position in shares of Bruker by 7.6% during the fourth quarter. Bank of New York Mellon Corp now owns 988,863 shares of the medical research company's stock worth $57,967,000 after acquiring an additional 69,806 shares during the last quarter. Blue Trust Inc. increased its stake in Bruker by 13.5% in the fourth quarter. Blue Trust Inc. now owns 2,164 shares of the medical research company's stock valued at $127,000 after purchasing an additional 257 shares during the period. Finally, Allspring Global Investments Holdings LLC lifted its position in Bruker by 1.8% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 214,580 shares of the medical research company's stock worth $12,619,000 after acquiring an additional 3,819 shares during the period. 79.52% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Bruker Price Performance

NASDAQ BRKR traded up $0.69 during mid-day trading on Friday, hitting $38.76. The stock had a trading volume of 3,139,890 shares, compared to its average volume of 1,467,987. The company has a 50 day simple moving average of $46.16 and a 200 day simple moving average of $54.75. The company has a quick ratio of 0.77, a current ratio of 1.60 and a debt-to-equity ratio of 1.15. The company has a market cap of $5.88 billion, a price-to-earnings ratio of 51.00, a P/E/G ratio of 2.16 and a beta of 1.18. Bruker Co. has a 52-week low of $34.10 and a 52-week high of $90.03.

Bruker (NASDAQ:BRKR - Get Free Report) last announced its quarterly earnings results on Thursday, February 13th. The medical research company reported $0.76 earnings per share for the quarter, beating analysts' consensus estimates of $0.75 by $0.01. Bruker had a return on equity of 21.01% and a net margin of 3.36%. Equities analysts forecast that Bruker Co. will post 2.69 EPS for the current fiscal year.

Bruker Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 28th. Shareholders of record on Monday, March 17th were issued a $0.05 dividend. This represents a $0.20 annualized dividend and a dividend yield of 0.52%. The ex-dividend date of this dividend was Monday, March 17th. Bruker's dividend payout ratio (DPR) is presently 26.32%.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the stock. Citigroup dropped their price objective on shares of Bruker from $75.00 to $50.00 and set a "buy" rating on the stock in a research note on Monday. Stifel Nicolaus dropped their price target on shares of Bruker from $70.00 to $57.00 and set a "hold" rating on the stock in a research note on Friday, February 14th. Guggenheim restated a "buy" rating on shares of Bruker in a research report on Monday, February 24th. Bank of America lifted their price objective on Bruker from $78.00 to $80.00 and gave the company a "buy" rating in a report on Friday, December 13th. Finally, Barclays cut their target price on Bruker from $60.00 to $50.00 and set an "overweight" rating for the company in a research note on Thursday. Six equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $66.50.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.